文献速递母胎医学

无症状胎儿产前诊断中孟德尔病筛查的外显子组测序检出率:1766例回顾性分析

Yield of Exome Sequencing for Mendelian Disorders Screening in Asymptomatic Fetuses Undergoing Prenatal Diagnosis: A Retrospective Analysis of 1766 Cases.
PubMed 文献 · Prenat Diagn · 2025-07-22

本研究回顾性分析2021至2022年在中山大学附属第三医院接受产前外显子组测序的1766例无症状单胎胎儿,排除超声异常及孟德尔病家族史者。检出25例(1.42%)携带可能导致中重度疾病的基因变异,阳性者中92%活产,73.91%随访至3岁,部分临床表型与测序结果高度或部分吻合。作者认为外显子组测序作为无症状胎儿的常规筛查可提高孟德尔病检出,但无表型时变异解读存在挑战。

要点

  • 无症状胎儿产前外显子组测序检出可能导致中重度疾病的变异率为1.42%(25/1766)。
  • 检出基因中73.91%为常染色体显性遗传,21.74%为常染色体隐性遗传,4.35%为X连锁隐性遗传。
  • 阳性病例中40%(10/25)有严重疾病风险,60%(15/25)有中度疾病风险。

核心结论

  • 外显子组测序作为无症状胎儿产前诊断的常规检测可提高孟德尔病检出,为父母提供胎儿健康信息、生殖选择及产前或产后医学干预的潜在可能。
  • 无表型时变异解读存在挑战,阳性病例结局存在不确定性风险。

研究设计与样本

  • 回顾性分析2021至2022年中山大学附属第三医院2593例接受产前外显子组测序的胎儿,排除827例超声异常或确诊/疑似孟德尔病家族史者,最终纳入1766例无症状单胎外显子组测序数据。

主要发现

  • 检出25例携带30个变异,涉及23个基因,检出率为1.42%(25/1766)。
  • 基因遗传方式:常染色体显性73.91%,常染色体隐性21.74%,X连锁隐性4.35%。
  • 30个变异中,致病性23.33%,可能致病性73.33%,意义未明3.33%。
  • 变异类型:错义23.33%,无义33.33%,移码缺失26.67%,剪接区13.33%,框内缺失3.33%。
  • 阳性病例中40%(10/25)有严重疾病风险,60%(15/25)有中度疾病风险;92%(23/25)活产,73.91%(17/23)有效随访至3岁,其中2例临床表型高度符合外显子组测序结果,2例部分符合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to evaluate the yield of exome sequencing (ES) as a routine screening test for Mendelian disorders in asymptomatic fetuses undergoing prenatal diagnosis, with a focus on identifying gene variants associated with moderate to severe diseases. METHODS: A total of 2593 fetuses underwent prenatal ES (pES) testing at the Third Affiliated Hospital of Sun Yat-Sen University between 2021 and 2022. Out of these, we excluded 827 pES datasets from fetuses with abnormal ultrasound findings, as well as those with a confirmed/suspected family history of Mendelian disorders. Consequently, a cohort of 1766 singleton ES datasets from asymptomatic fetuses was included in this study and subsequently subjected to retrospective analysis. RESULTS: We identified 25 cases with 30 variants in 23 genes that may present with moderate to severe diseases, giving a yield of 1.42% (25/1766). Among these genes, 73.91% were associated with autosomal dominant (AD) inheritance, 21.74% with autosomal recessive (AR) inheritance, and 4.35% with X-linked recessive (XLR) inheritance. Of the 30 identified variants, 23.33% were classified as pathogenic, 73.33% as likely pathogenic, and 3.33% as variants of uncertain significance. The types of variants included missense (23.33%), nonsense (33.33%), frameshift deletion (26.67%), splicing region (13.33%), and inframe deletion (3.33%). Clinically, 40% (10/25) of the cases were at risk of severe diseases, and 60% (15/25) of the cases were at risk of moderate diseases. Of the positive cases, 92% (23/25) were liveborn, and 73.91% (17/23) were effectively followed up to the age of three. Among these 17 cases, two exhibited clinical presentations that highly met the criteria for ES findings, while two exhibited clinical presentations that partially met the criteria. CONCLUSION: The findings of this study suggest that application of ES as a routine test in asymptomatic fetuses undergoing prenatal diagnosis could enhance the detection of Mendelian disorders, thereby providing information to parents about the health of their fetus, providing them with reproductive options, as well as providing the potential for medical interventions prenatally or postnatally. However, challenges may arise in variant interpretation in the absence of phenotype, along with the risk of uncertain outcomes for positive cases.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Wang G, Xue T, Xie T, et al. Yield of Exome Sequencing for Mendelian Disorders Screening in Asymptomatic Fetuses Undergoing Prenatal Diagnosis: A Retrospective Analysis of 1766 Cases. Prenat Diagn. 2025. PMID: 40696565. doi:10.1002/pd.6853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。